BOSTON – Today, the Massachusetts Senate passed An Act relative to Pharmaceutical Access, Costs and Transparency (PACT Act), comprehensive pharmaceutical cost control legislation aimed at addressing the high and rapidly increasing costs of prescription drugs. By connecting the need for greater drug price transparency with policies to improve oversight over the pharmaceutical industry, the legislation will put Massachusetts at the forefront of the state’s efforts to tackle increasing drug costs. It will also reduce drug costs to patients and lower health care costs overall.
“This bill will bring us one step closer toward addressing rising costs within our healthcare system that continually impact patients’ ability to access the care they need,” said Senator Cindy F. Friedman (D-Arlington), co-chair of the Joint Committee on Health Care Financing. “By reining in prescription drug costs and increasing transparency and oversight within the pharmaceutical industry, we can drive down costs and improve patient outcomes. I want to thank Senate President Spilka and Chair Rodrigues for their hard work and collaboration throughout this process. I look forward to advocating for this important initiative throughout the remainder of this session.”